XBI

SPDR S&P Biotech ETF

Up$87.63
+$0.14
(+0.16%)
As of 7:40:00 PM EDT | 11/21/19  |  Market Closed

XBI Trading Data

Open

$87.76

Low Price

$86.68

High Price

$87.76

Previous Last Price

$87.49

Bid Size

$86.39 X 100

Ask Size

$88.17 X 100

XBI Portfolio Data

AUM

$4,158,912,800

Shares

47,525

PE Ratio

15.67

Price / Book Ratio

4.24

Expense Ratio

0.35

Net Asset Value

$87.51

Volume

Volume

5,574,000

Avg. Volume (YDT)

4,673,222

Dollar Volume

$205,890,419

Weekly Avg. Volume

5,330,640

Monthly Avg. Volume

3,904,670

Quarterly Avg. Volume

4,682,640

XBI Fund Description

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

XBI Chart

XBI Summary

Fund Family

State Street Global Advisors

Tracks This Index

SPDR S&P Biotech ETF

Inception Date

2006-01-31

Asset Class

Equity

Asset Class Size

Biotech

XBI Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

XBI Holdings

Top 10 Holdings

Arrowhead Pharmaceuticals Inc. (ARWR)
2.59%
Seattle Genetics Inc. (SGEN)
2.57%
Medicines Company (MDCO)
2.26%
AbbVie Inc. (ABBV)
1.94%
Intercept Pharmaceuticals Inc. (ICPT)
1.91%
Vertex Pharmaceuticals Incorporated (VRTX)
1.89%
Regeneron Pharmaceuticals Inc. (REGN)
1.88%
Biogen Inc. (BIIB)
1.86%
Alnylam Pharmaceuticals Inc (ALNY)
1.8%
Neurocrine Biosciences Inc. (NBIX)
1.8%

Total XBI Holdings

Total Holdings: 119

Arrowhead Pharmaceuticals Inc. (ARWR)
2.59%
Seattle Genetics Inc. (SGEN)
2.57%
Medicines Company (MDCO)
2.26%
AbbVie Inc. (ABBV)
1.94%
Intercept Pharmaceuticals Inc. (ICPT)
1.91%
Vertex Pharmaceuticals Incorporated (VRTX)
1.89%
Regeneron Pharmaceuticals Inc. (REGN)
1.88%
Biogen Inc. (BIIB)
1.86%
Alnylam Pharmaceuticals Inc (ALNY)
1.8%
Neurocrine Biosciences Inc. (NBIX)
1.8%
Incyte Corporation (INCY)
1.77%
Amgen Inc. (AMGN)
1.77%
United Therapeutics Corporation (UTHR)
1.76%
Sarepta Therapeutics Inc. (SRPT)
1.75%
Mirati Therapeutics Inc. (MRTX)
1.72%
Celgene Corporation (CELG)
1.69%
Repligen Corporation (RGEN)
1.67%
BioMarin Pharmaceutical Inc. (BMRN)
1.65%
Ligand Pharmaceuticals Incorporated (LGND)
1.64%
Alexion Pharmaceuticals Inc. (ALXN)
1.58%
Global Blood Therapeutics Inc (GBT)
1.57%
Spark Therapeutics Inc. (ONCE)
1.55%
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
1.54%
Gilead Sciences Inc. (GILD)
1.5%
Amicus Therapeutics Inc. (FOLD)
1.5%
Blueprint Medicines Corp. (BPMC)
1.5%
SAGE Therapeutics Inc. (SAGE)
1.42%
Invitae Corp. (NVTA)
1.38%
ACADIA Pharmaceuticals Inc. (ACAD)
1.37%
Immunomedics Inc. (IMMU)
1.35%
Ionis Pharmaceuticals Inc. (IONS)
1.35%
Exelixis Inc. (EXEL)
1.32%
Iovance Biotherapeutics Inc (IOVA)
1.31%
Exact Sciences Corporation (EXAS)
1.21%
Portola Pharmaceuticals Inc. (PTLA)
1.17%
Insmed Incorporated (INSM)
1.12%
FibroGen Inc. (FGEN)
1.11%
Arena Pharmaceuticals Inc. (ARNA)
1.09%
bluebird bio Inc. (BLUE)
1.09%
Ra Pharmaceuticals Inc. (RARX)
1.08%
REGENXBIO Inc. (RGNX)
1.06%
Alkermes Plc (ALKS)
1.03%
Esperion Therapeutics Inc. (ESPR)
1.02%
Agios Pharmaceuticals Inc. (AGIO)
1.01%
CareDx Inc. (CDNA)
0.96%
PTC Therapeutics Inc. (PTCT)
0.95%
Natera Inc. (NTRA)
0.9%
Ultragenyx Pharmaceutical Inc. (RARE)
0.88%
Adverum Biotechnologies Inc (ADVM)
0.86%
Myriad Genetics Inc. (MYGN)
0.85%
Madrigal Pharmaceuticals Inc. (MDGL)
0.83%
ArQule Inc. (ARQL)
0.81%
Karyopharm Therapeutics Inc. (KPTI)
0.73%
Ironwood Pharmaceuticals Inc. Class A (IRWD)
0.73%
Veracyte Inc (VCYT)
0.72%
Coherus BioSciences Inc. (CHRS)
0.72%
Allakos Inc. (ALLK)
0.71%
Halozyme Therapeutics Inc. (HALO)
0.71%
Emergent BioSolutions Inc. (EBS)
0.7%
Xencor Inc. (XNCR)
0.69%
Editas Medicine Inc. (EDIT)
0.68%
Heron Therapeutics Inc (HRTX)
0.65%
Sangamo Therapeutics Inc. (SGMO)
0.62%
Enanta Pharmaceuticals Inc. (ENTA)
0.61%
Atara Biotherapeutics Inc (ATRA)
0.55%
Audentes Therapeutics Inc. (BOLD)
0.54%
Aimmune Therapeutics Inc (AIMT)
0.54%
Fate Therapeutics Inc. (FATE)
0.54%
Athenex Inc. (ATNX)
0.52%
Acceleron Pharma Inc (XLRN)
0.51%
Vanda Pharmaceuticals Inc. (VNDA)
0.51%
Epizyme Inc. (EPZM)
0.5%
Puma Biotechnology Inc. (PBYI)
0.47%
Deciphera Pharmaceuticals Inc. (DCPH)
0.45%
Viking Therapeutics Inc. (VKTX)
0.45%
Vericel Corporation (VCEL)
0.44%
TG Therapeutics Inc. (TGTX)
0.44%
ZIOPHARM Oncology Inc. (ZIOP)
0.43%
Dicerna Pharmaceuticals Inc. (DRNA)
0.42%
Apellis Pharmaceuticals Inc. (APLS)
0.41%
Allogene Therapeutics Inc. (ALLO)
0.41%
Retrophin Inc. (RTRX)
0.4%
Intrexon Corporation (XON)
0.4%
Intellia Therapeutics Inc. (NTLA)
0.37%
Radius Health Inc (RDUS)
0.36%
Anika Therapeutics Inc. (ANIK)
0.34%
Krystal Biotech Inc. (KRYS)
0.34%
Eagle Pharmaceuticals Inc. (EGRX)
0.33%
Flexion Therapeutics Inc. (FLXN)
0.31%
Turning Point Therapeutics Inc. (TPTX)
0.3%
Voyager Therapeutics Inc. (VYGR)
0.3%
Stemline Therapeutics Inc. (STML)
0.3%
AMAG Pharmaceuticals Inc. (AMAG)
0.3%
Momenta Pharmaceuticals Inc. (MNTA)
0.28%
G1 Therapeutics Inc. (GTHX)
0.27%
ImmunoGen Inc. (IMGN)
0.26%
Achillion Pharmaceuticals Inc. (ACHN)
0.26%
Spectrum Pharmaceuticals Inc. (SPPI)
0.25%
Twist Bioscience Corp. (TWST)
0.23%
OPKO Health Inc. (OPK)
0.22%
Denali Therapeutics Inc. (DNLI)
0.21%
Kura Oncology Inc. (KURA)
0.21%
MacroGenics Inc. (MGNX)
0.19%
Catalyst Pharmaceuticals Inc. (CPRX)
0.18%
STATE STREET INSTL US GOVERNME STIF USD (85749246)
0.18%
Progenics Pharmaceuticals Inc. (PGNX)
0.18%
Akcea Therapeutics Inc. (AKCA)
0.16%
Cytokinetics Incorporated (CYTK)
0.16%
AnaptysBio Inc. (ANAB)
0.16%
Rocket Pharmaceuticals Inc. (RCKT)
0.15%
Rhythm Pharmaceuticals Inc. (RYTM)
0.15%
BioCryst Pharmaceuticals Inc. (BCRX)
0.13%
Homology Medicines Inc. (FIXX)
0.12%
Akebia Therapeutics Inc. (AKBA)
0.1%
Prothena Corp. Plc (PRTA)
0.1%
AVROBIO Inc (AVRO)
0.1%
CytomX Therapeutics Inc. (CTMX)
0.08%
U.S. Dollar
0.01%
SPDR S & P Biotech ETF (XBI)
0%

XBI Technicals

Alpha

-6.34

Beta

1.64

Leverage

Long

Standard Deviation

4.92

XBI Dividends

Dividend Date

2019-09-20

Latest Dividend

0.003

Annual Dividend

0.02

Annual Dividend Rate

0.02

Annual Dividend Yield

0.02

XBI Performance

YTD Return

22.13%

1 Year Return

12.53%

3 Year Return

31.97%

5 Year Return

46.2%

10 Year Return

424%

XBI Related Articles

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.